Insmed Incorporated
Nasdaq 100
$129.41
+1.67%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Moderate debt: debt-to-equity of 0.77.
- Current assets comfortably cover current liabilities (current ratio 3.83).
!Watch-points
- Thin interest cover: operating profit covers interest only about -14.9 times.
- Return on equity is on the lower side at -181.1%.
- Return on capital employed is on the lower side at -77.6%.
- The company reported a net loss in the latest period.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
5.79
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Piotroski F-ScoreWeak
3 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$28.26B
Current Price$ 129.41
High / Low$ 212.75 / 90.39
Stock P/E-20.16
Book Value$ 3.27
Dividend Yield0%
ROCE-77.58%
ROE-181.14%
Debt to Equity0.77
Current Ratio3.83
P/B Ratio37.29395
EPS$ -6.42
Debt$540.96M
PAT Margin-210.54%
Cash PAT$-1.27B
ICR-14.88